Flora Vitale

580 total citations
16 papers, 401 citations indexed

About

Flora Vitale is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Flora Vitale has authored 16 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Neurology. Recurrent topics in Flora Vitale's work include Glioma Diagnosis and Treatment (6 papers), Neurological disorders and treatments (4 papers) and Transcranial Magnetic Stimulation Studies (4 papers). Flora Vitale is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Neurological disorders and treatments (4 papers) and Transcranial Magnetic Stimulation Studies (4 papers). Flora Vitale collaborates with scholars based in Italy, United States and Spain. Flora Vitale's co-authors include Giovanni Luca Gravina, Claudio Festuccia, Francesco Marampon, Alessandro Colapietro, A. Mancini, Andrea Mancini, Simona Delle Monache, Antonella Vetuschi, Peter J. Richardson and Stephen A. Burbidge and has published in prestigious journals such as Brain Research, International Journal of Molecular Sciences and Journal of Neurochemistry.

In The Last Decade

Flora Vitale

16 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Flora Vitale Italy 12 187 117 88 63 51 16 401
Annamaria Russo Italy 8 209 1.1× 139 1.2× 140 1.6× 47 0.7× 36 0.7× 19 430
Ruifan Xie China 11 189 1.0× 99 0.8× 131 1.5× 85 1.3× 45 0.9× 19 372
Maria Patrizia Mongiardi Italy 13 289 1.5× 59 0.5× 57 0.6× 97 1.5× 55 1.1× 20 458
Pítia Flores Ledur Brazil 10 217 1.2× 99 0.8× 135 1.5× 61 1.0× 21 0.4× 11 441
Caroline Mysiorek France 14 219 1.2× 115 1.0× 41 0.5× 39 0.6× 107 2.1× 21 606
Ramcharan Singh Angom United States 10 194 1.0× 60 0.5× 44 0.5× 78 1.2× 42 0.8× 26 384
Mario Mauri Italy 12 356 1.9× 69 0.6× 98 1.1× 90 1.4× 41 0.8× 30 587
Zhangqi Dou China 12 146 0.8× 60 0.5× 45 0.5× 69 1.1× 56 1.1× 21 329
Marcin Teodorczyk Germany 5 168 0.9× 64 0.5× 40 0.5× 70 1.1× 106 2.1× 5 414
Cécile Thirant France 13 408 2.2× 141 1.2× 114 1.3× 170 2.7× 33 0.6× 18 594

Countries citing papers authored by Flora Vitale

Since Specialization
Citations

This map shows the geographic impact of Flora Vitale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flora Vitale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flora Vitale more than expected).

Fields of papers citing papers by Flora Vitale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flora Vitale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flora Vitale. The network helps show where Flora Vitale may publish in the future.

Co-authorship network of co-authors of Flora Vitale

This figure shows the co-authorship network connecting the top 25 collaborators of Flora Vitale. A scholar is included among the top collaborators of Flora Vitale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flora Vitale. Flora Vitale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Colapietro, Alessandro, Peiying Yang, A. Mancini, et al.. (2022). The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma. Frontiers in Pharmacology. 13. 852941–852941. 7 indexed citations
2.
Insola, Angelo, et al.. (2021). Pedunculopontine tegmental Nucleus-evoked prepulse inhibition of the blink reflex in Parkinson’s disease. Clinical Neurophysiology. 132(10). 2729–2738. 2 indexed citations
3.
Colapietro, Alessandro, A. Mancini, Flora Vitale, et al.. (2020). Crocetin Extracted from Saffron Shows Antitumor Effects in Models of Human Glioblastoma. International Journal of Molecular Sciences. 21(2). 423–423. 39 indexed citations
4.
Colapietro, Alessandro, Peiying Yang, A. Mancini, et al.. (2020). The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties. Frontiers in Pharmacology. 11. 552428–552428. 20 indexed citations
5.
Festuccia, Claudio, Andrea Mancini, Alessandro Colapietro, et al.. (2018). The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma. Journal of Hematology & Oncology. 11(1). 32–32. 48 indexed citations
6.
Romeo, Stefania, Flora Vitale, Cristina Viaggi, et al.. (2017). Fluorescent light induces neurodegeneration in the rodent nigrostriatal system but near infrared LED light does not. Brain Research. 1662. 87–101. 16 indexed citations
7.
Gravina, Giovanni Luca, A. Mancini, Francesco Marampon, et al.. (2017). The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma. Journal of Hematology & Oncology. 10(1). 5–5. 54 indexed citations
8.
Gravina, Giovanni Luca, Andrea Mancini, Alessandro Colapietro, et al.. (2017). The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models. Tumor Biology. 39(6). 3726131152–3726131152. 44 indexed citations
9.
Gravina, Giovanni Luca, Andrea Mancini, Claudia De Mattei, et al.. (2017). Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models. Oncotarget. 8(18). 29865–29886. 11 indexed citations
10.
Vignaroli, Gianluca, Claudio Zamperini, Claudio Festuccia, et al.. (2016). Suppression of SRC Signaling Is Effective in Reducing Synergy between Glioblastoma and Stromal Cells. Molecular Cancer Therapeutics. 15(7). 1535–1544. 30 indexed citations
11.
12.
Scarnati, Eugenio, et al.. (2016). Cholinergic input from the pedunculopontine nucleus to the cerebellum: implications for deep brain stimulation in Parkinson′s disease. Neural Regeneration Research. 11(5). 729–729. 4 indexed citations
13.
Chassain, Carine, Christophe Melon, Pascal Salin, et al.. (2015). Metabolic, synaptic and behavioral impact of 5‐week chronic deep brain stimulation in hemiparkinsonian rats. Journal of Neurochemistry. 136(5). 1004–1016. 21 indexed citations
14.
Gravina, Giovanni Luca, Andrea Mancini, Patrizia Sanità, et al.. (2015). KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models. BMC Cancer. 15(1). 8–8. 49 indexed citations
15.
Gravina, Giovanni Luca, A. Mancini, Luca Scarsella, et al.. (2015). Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models. Tumor Biology. 37(1). 341–351. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026